A detailed history of Bank Of Montreal transactions in Ab Cellera Biologics Inc. stock. As of the latest transaction made, Bank Of Montreal holds 58,013 shares of ABCL stock, worth $169,397. This represents 0.0% of its overall portfolio holdings.

Number of Shares
58,013
Previous 41,659 39.26%
Holding current value
$169,397
Previous $123,000 21.95%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$2.39 - $3.49 $39,086 - $57,075
16,354 Added 39.26%
58,013 $150,000
Q2 2024

Aug 14, 2024

SELL
$2.73 - $4.73 $6,737 - $11,673
-2,468 Reduced 5.59%
41,659 $123,000
Q1 2024

May 13, 2024

BUY
$4.29 - $5.97 $54,414 - $75,723
12,684 Added 40.34%
44,127 $199,000
Q4 2023

Feb 08, 2024

SELL
$3.91 - $5.93 $117,616 - $178,380
-30,081 Reduced 48.89%
31,443 $179,000
Q3 2023

Nov 01, 2023

SELL
$4.6 - $7.95 $13,422 - $23,198
-2,918 Reduced 4.53%
61,524 $283,000
Q2 2023

Aug 02, 2023

BUY
$5.66 - $7.59 $5,688 - $7,627
1,005 Added 1.58%
64,442 $416,000
Q1 2023

Jun 13, 2024

BUY
$7.31 - $11.18 $180,483 - $276,034
24,690 Added 55.95%
68,817 $518,000
Q4 2022

Feb 01, 2023

SELL
$9.48 - $14.52 $789,788 - $1.21 Million
-83,311 Reduced 56.77%
63,437 $642,000
Q3 2022

Nov 10, 2022

SELL
$9.2 - $13.68 $1.76 Million - $2.61 Million
-190,902 Reduced 56.54%
146,748 $1.55 Million
Q2 2022

Aug 11, 2022

BUY
$5.72 - $10.65 $1.2 Million - $2.23 Million
209,148 Added 162.76%
337,650 $3.47 Million
Q1 2022

May 12, 2022

BUY
$7.46 - $14.14 $190,438 - $360,965
25,528 Added 24.79%
128,502 $1.27 Million
Q4 2021

Feb 11, 2022

SELL
$12.99 - $17.73 $162,245 - $221,447
-12,490 Reduced 10.82%
102,974 $1.5 Million
Q3 2021

Nov 12, 2021

BUY
$14.85 - $21.34 $638,163 - $917,065
42,974 Added 59.28%
115,464 $2.25 Million
Q2 2021

Aug 12, 2021

BUY
$20.19 - $34.17 $1.46 Million - $2.48 Million
72,490 New
72,490 $1.55 Million

Others Institutions Holding ABCL

About AbCellera Biologics Inc.


  • Ticker ABCL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 285,139,008
  • Market Cap $833M
  • Description
  • AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...
More about ABCL
Track This Portfolio

Track Bank Of Montreal Portfolio

Follow Bank Of Montreal and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Montreal with notifications on news.